{
    "medicine_id": "a213a79eedec53d4bf4fe6de53984ba66339e1bc",
    "platform_id": "DB11157",
    "metadata": {
        "name": "Anthraforte 1 Ointment 1 500 mg 100g Cream",
        "composition": "500 mg 100g Anthralin",
        "clinical_particulars": {
            "therapeutic_indications": "Stable plaque psoriasis of the skin and scalp L1933 It is also used topically in the management of psoriasis dermatoses and alopecia areata Anthralin is also used in biomedical research due to its effect on EGFR autophosphorylation L1936",
            "contraindications": {
                "disease": "Some mild adverse effects include alterations in nail coloring hair coloring increase in photosensitivity and skin irritation L1933 The most common side effects of anthralin are skin irritation and staining of nearby skin nails clothing and other objects that come in contact with the treated patient The incidence of irritation of psoriatic surrounding healthy skin is higher in patients who leave anthralin on the skin without rinsing than in those who use short contact therapy of 2 hours or less followed by rinsing L1939 If the psoriatic plaques are well circumscribed the surrounding normal skin may be protected by the use of a coating agent such as zinc oxide ointment Anthralin should be applied cautiously to the face and intertriginous areas due to the risk of severe skin irritation L1979 There is no current evidence of any long term anthralin toxicity related either to skin exposure or to systemic issues L1939 Some long term studies in mice have demonstrated anthralin to be tumorigenic in mouse skin This carcinogenic potential has not been thoroughly evaluated Tumorigenic and carcinogenic effects of anthralin have not been observed in humans at this time L1932 Anthralin is classified as FDA pregnancy risk category C drug L1979 It is not known if anthralin can cause fetal harm when administered during gestation Because of the lack of evidential human data anthralin should be used during pregnancy only when clearly required L1933",
                "pregnancy": "NA",
                "machine_ops": "NA",
                "pharmacodynamics": "Anthralin is a natural anthraquinone derivative anti psoriatic and anti inflammatory agent It controls skin growth by reducing the synthesis of DNA and the mitotic activity in the hyperplastic epidermis normalizing the rate of cell proliferation and keratinization L1936",
                "excipients": "NA",
                "incompatibilities": []
            }
        },
        "revision_date": "2023-05-14"
    }
}